New Orleans, LA8 Active Studies

Advanced Solid Tumors Clinical Trials in New Orleans, LA

Find 8 actively recruiting advanced solid tumors clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

8
Active Trials
8
Sponsors
2,082
Enrolling

Recruiting Advanced Solid Tumors Studies in New Orleans

NCT05768139Recruiting

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Study STX-478-101 is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478 (LY4064809) in participants with...

New Orleans, LAPHASE1880 participantsEli Lilly and Company
View Study Details
NCT06792552Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors...

New Orleans, LAPHASE1414 participantsNextCure, Inc.
View Study Details
NCT06656390Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), open-label, multicenter dose escalation and expansion study of ALK201. The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and ant...

New Orleans, LAPHASE1202 participantsShanghai Allink Biotherapeutics Co., Ltd.
View Study Details
NCT05270213Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

RBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endo...

New Orleans, LAPHASE1164 participantsRiboscience, LLC.
View Study Details
NCT06657144Recruiting

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanc...

New Orleans, LAPHASE1154 participantsCoherus Oncology, Inc.
View Study Details
NCT06014502Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

The purpose of this Phase 1a/1b clinical trial is to test the safety of an investigational drug called IMGS-001 and to determine how well it can work in treating patients with advanced solid tumors th...

New Orleans, LAPHASE1105 participantsImmunoGenesis
View Study Details
NCT05277168Recruiting

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

The study (dose escalation/expansion) is being conducted to assess the safety and tolerability of SHR-A1904 in subjects with advanced solid tumors, and to determine maximum tolerated dose (MTD) and/or...

New Orleans, LAPHASE183 participantsJiangsu HengRui Medicine Co., Ltd.
View Study Details
NCT06730347Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Study CP-MGD019-03 is an open-label study of lorigerlimab in participants with platinum-resistant ovarian cancer (PROC) or clear cell gynecologic cancer (CCGC). Approximately 60 participants will be e...

New Orleans, LAPHASE280 participantsMacroGenics
View Study Details

About Advanced Solid Tumors Clinical Trials in New Orleans

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 8 advanced solid tumors clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 2,082 participants. Research is being sponsored by Eli Lilly and Company, NextCure, Inc., Shanghai Allink Biotherapeutics Co., Ltd. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in New Orleans — FAQ

Are there advanced solid tumors clinical trials in New Orleans?

Yes, there are 8 advanced solid tumors clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 8 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 18, 2026 from ClinicalTrials.gov